- Price is above Fair Value, showing premium demand versus the model.
MEDS
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Hetzer Medical Indonesia Tbk · Healthcare · Medical Instruments & Supplies
Latest close
74.00 IDR
-2.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.3% below the Trend Line and sits at 22.4% of its 52-week range. The latest completed week returned -2.6%, after a -8.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
74.00 IDR
7 Aug 2026
1W Return
-2.6%
latest completed week
4W Return
-8.6%
short-term follow-through
12W Return
-30.2%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 40.98% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.6%
Latest completed week; four-week move -8.6%.
Indicator stack
38/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.98%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.3% below the Trend Line and sits at 22.4% of its 52-week range. The latest completed week returned -2.6%, after a -8.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3012-week average 0.37
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.30Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -8.6% over four weeks, -30.2% over 12 weeks, and 48.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.39Latest activity-pressure read.
Pressure change-885.0%Four-week change in activity pressure.
Leadership16.59Latest relative-leadership reading.
RS change-62.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.9%Distance below the 52-week high.
13-week volatility9.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2614 weeks finished lower.
Best week+51.9%Week of 8 May.
Worst week-22.2%Week of 5 Jun.
Latest week-2.6%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains3
Flat weeks2
Modest losses5
Sharp losses9
Recent vol9.3%13-week weekly-return volatility.
Base vol13.0%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew11.4% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank35 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Instruments & Supplies
4-week rank4 / 4
Group average3.5%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS75.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis50/100Latest 12-week confirmation: trend 5/12, activity pressure 5/12, relative leadership 12/12.
Activity pressure 0.30; 1 reversal markers Next-Week ExpectancyNegative 40.98%Next-week expectancy is negative with a 40.98% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
PT Hetzer Medical Indonesia Tbk Revenue Breakdown – IDX:MEDS Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 74.00 IDR | -2.6% | 75.73 IDR | 59.62 IDR | -0.39 | 16.59 | 151.6M | Off |
| 31 Jul 2026 | 76.00 IDR | 0.0% | 76.00 IDR | 59.67 IDR | -0.16 | 24.25 | 111.7M | Off |
| 24 Jul 2026 | 76.00 IDR | -5.0% | 75.87 IDR | 59.70 IDR | -0.12 | 26.42 | 168.1M | Off |
| 17 Jul 2026 | 80.00 IDR | -1.2% | 75.80 IDR | 59.79 IDR | -0.06 | 35.04 | 546.8M | On |
| 10 Jul 2026 | 81.00 IDR | 19.1% | 75.57 IDR | 59.89 IDR | -0.04 | 44.29 | 1.3B | Off |
| 3 Jul 2026 | 68.00 IDR | -1.4% | 75.60 IDR | 59.99 IDR | -0.11 | 23.79 | 32.3M | Off |
| 26 Jun 2026 | 69.00 IDR | -6.8% | 76.53 IDR | 60.17 IDR | -0.02 | 26.29 | 10.7M | Off |
| 19 Jun 2026 | 74.00 IDR | 1.4% | 77.33 IDR | 60.32 IDR | 0.17 | 30.48 | 16.0M | Off |
| 12 Jun 2026 | 73.00 IDR | 4.3% | 76.97 IDR | 60.47 IDR | 0.45 | 33.68 | 32.1M | On |
| 5 Jun 2026 | 70.00 IDR | -22.2% | 76.63 IDR | 60.58 IDR | 0.76 | 39.17 | 34.2M | On |
| 29 May 2026 | 90.00 IDR | -1.1% | 76.43 IDR | 60.71 IDR | 1.05 | 65.32 | 391.8M | On |
| 22 May 2026 | 91.00 IDR | -14.2% | 75.60 IDR | 60.59 IDR | 0.91 | 69.04 | 1.7B | On |
| 15 May 2026 | 106.0 IDR | -9.4% | 74.97 IDR | 60.58 IDR | 0.68 | 83.63 | 2.4B | On |
| 8 May 2026 | 117.0 IDR | 51.9% | 73.77 IDR | 60.51 IDR | 0.22 | 99.43 | 1.3B | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.